Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Karen Dorothee Larbig has worked on the following 15 EPO patent applications which have been published in the last five years:

EP11751752

TREATMENT OF HYPERTENSION AND/OR PREVENTION OR TREATMENT OF HEART FAILURE IN A MAMMAL RECEIVING ANTI-COAGULANT THERAPY

IPC classification:
A61K 31/221, A61K 31/41, A61P 9/00, A61P 9/04, A61P 9/12
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Agent:
Karen Dorothee Larbig, Novartis Pharma GmbH
Status:
EXAMINATION IN PROGRESS
EP11779278

PHARMACEUTICAL COMPOSITIONS CONTAINING A DGAT1 INHIBITOR

IPC classification:
A61K 9/20, A61K 31/444, A61K 47/20, A61K 47/26, A61K 47/38
Applicant:
Novartis AG
Agent:
Karen Dorothee Larbig, Novartis Pharma GmbH
Status:
EXAMINATION IN PROGRESS
EP12756614

USE OF ORGANIC COMPOUND FOR THE TREATMENT OF NOONAN SYNDROME

IPC classification:
A61K 31/166, A61P 43/00
Applicant:
Novartis AG
Agent:
Garreth Andrew Duncan, D Young & Co LLP
Agent:
Karen Dorothee Larbig, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12758966

PHARMACEUTICAL COMPOSITIONS COMPRISING AN AROMATASE INHIBITOR

IPC classification:
A61K 9/48, A61K 31/4196, A61P 5/26, A61P 15/08, A61P 35/00
Applicant:
Novartis AG
Agent:
Lionel Paul Clarke, Gill Jennings & Every LLP
Agent:
Karen Dorothee Larbig, Novartis Pharma AG
Status:
PATENT GRANTED
EP12758965

USE OF AN AROMATASE INHIBITOR FOR THE TREATMENT OF HYPOGONADISM AND RELATED DISEASES

IPC classification:
A61K 9/48, A61K 31/4196, A61P 5/26, A61P 15/08
Applicant:
Novartis AG
Agent:
Lionel Paul Clarke, Gill Jennings & Every LLP
Agent:
Karen Dorothee Larbig, Novartis Pharma AG
Status:
PATENT GRANTED
EP13750725

NEP INHIBITORS FOR TREATING DISEASES CHARACTERIZED BY ATRIAL ENLARGEMENT OR REMODELING

IPC classification:
A61K 31/194, A61K 31/197, A61K 31/216, A61K 31/4192, A61K 45/06
Applicant:
Novartis AG
Agent:
Karen Dorothee Larbig, Novartis Pharma AG
Status:
EXAMINATION IN PROGRESS
EP13832514

NEW PROCESS

IPC classification:
C07C 213/00, C07C 215/20
Applicant:
Novartis AG
Agent:
Karen Dorothee Larbig, Novartis Pharma AG
Agent:
Karen Dorothee Larbig, Novartis Pharma GmbH
Status:
GRANT OF PATENT INTENDED
EP11715329

USES OF DGAT1 INHIBITORS

IPC classification:
A61K 31/42
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Agent:
Karen Dorothee Larbig, Novartis Pharma GmbH
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13759384

NEW USE

IPC classification:
A61K 31/194, A61K 31/197, A61K 31/216, A61K 45/06, A61P 9/10, A61P 9/12
Applicant:
Novartis AG
Agent:
Karen Dorothee Larbig, Novartis Pharma GmbH
Status:
EXAMINATION IN PROGRESS
EP14761702

NEW USE

IPC classification:
A61K 31/194, A61K 31/197, A61K 31/216, A61K 31/221, A61K 31/41, A61K 45/06, A61P 9/10, A61P 9/12
Applicant:
Novartis AG
Agent:
Karen Dorothee Larbig, Novartis Pharma AG
Status:
EXAMINATION IN PROGRESS
EP11770622

NEW CRYSTALLINE FORMS OF THE SODIUM SALT OF (4- {4- [5- ( 6 - TRIFLUOROMETHYL - PYRIDIN- 3 - YLAMINO ) - PYRIDIN- 2 -YL]-PHENYL} - CYCLOHEXYL) -ACETIC ACID

IPC classification:
A61K 31/444, A61K 45/06, A61P 3/04, C07D 213/72, C07D 401/12
Applicant:
Novartis AG
Agent:
Karen Dorothee Larbig, Novartis Pharma GmbH
Status:
PATENT GRANTED
EP16157767

PHARMACEUTICAL COMPOSITIONS BASED ON SUPERSTRUCTURES OF ANGIOTENSIN RECEPTOR ANTAGONIST/BLOCKER (ARB) AND NEUTRAL ENDOPEPTIDASE (NEP) INHIBITOR

IPC classification:
A61K 9/00, A61K 9/20, A61K 31/216
Applicant:
Novartis AG
Agent:
Karen Dorothee Larbig, Novartis Pharma AG
Status:
EXAMINATION REQUESTED
EP11758422

NEW PROCESS FOR THE PREPARATION OF INTERMEDIATES USEFUL FOR THE MANUFACTURE OF NEP INHIBITORS

IPC classification:
C07C 227/18, C07C 227/20, C07C 227/22, C07C 229/30, C07C 229/34, C07C 231/10, C07C 269/06, C07C 271/22, C07D 207/24, C07D 207/267, C07D 207/27, C07D 207/277, C07D 207/33, C07D 207/38
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Agent:
Karen Dorothee Larbig, Novartis Pharma GmbH
Status:
PATENT GRANTED
EP11758421

PROCESS FOR THE PREPARATION OF INTERMEDIATES FOR THE MANUFACTURE OF NEP INHIBITORS

IPC classification:
C07C 269/06, C07C 271/22
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Agent:
Karen Dorothee Larbig, Novartis Pharma GmbH
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11734379

INTERMEDIATES OF NEUTRAL ENDOPEPTIDASE INHIBITORS AND PREPARATION METHOD THEREOF

IPC classification:
C07D 207/26, C07D 207/263, C07D 207/267, C07D 207/277, C07D 207/38
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Agent:
Karen Dorothee Larbig, Novartis Pharma GmbH
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT

Please Sign in to use this feature